Vaccination location:
***New as of 5/20/22***
Booster for kids age 5-11 approved
The CDC has approved kids age 5-11 to receive their 1st booster dose of the Pfizer vaccine as long as it has been at least 5 months since their last dose.
---------------------
2nd Booster Doses
Immunocompromised individuals and people over the age of 50 who received an initial booster dose at least 4 months ago are now eligible for another mRNA booster to increase their protection against severe disease from COVID-19.
Adults who received a primary vaccine and booster dose of Johnson & Johnson’s Janssen COVID-19 vaccine at least 4 months ago may now receive a second booster dose using an mRNA COVID-19 vaccine.
See FAQ for details
---------------------
Pfizer Only Booster doses now available for 12+ year olds at least 5 months after completing their 2nd dose of the Pfizer COVID-19 vaccine.
Pfizer only 3rd dose for moderate/severe immunocompromised children 5-11 authorized 28 days after their second dose.
See FAQ for additional details
---------------------
COVID-19 1st Booster doses for all adults available:
Pfizer - 5 months after their 2nd dose and age 12+
Moderna - 5 months after their 2nd dose and age 18+
J&J - 2 months after their 1st dose and age 18+
See FAQ for additional details
---------------------
Click the button below to schedule your Moderna vaccine. 3rd dose or booster eligible - see FAQ.
Click the button below to schedule your Johnson & Johnson vaccine. Booster eligible - see FAQ.
The Texas Department of State Health Services (DSHS) is alerting COVID-19 vaccine providers that the U.S. Food and Drug Administration (FDA) yesterday released new guidelines associated with the Johnson & Johnson/Janssen (J&J) COVID-19 vaccine. Citing the risk of thrombosis with thrombocytopenia syndrome (TTS), the FDA now limits the use of the J&J vaccine to the following groups:
TTS is a condition of rare and potentially life-threatening blood clots in combination with low levels of blood platelets. According to the FDA, symptoms of TTS would show approximately one to two weeks after receiving the J&J COVID-19 vaccine. In making the determination to limit the authorized use of the J&J COVID-19 Vaccine, the FDA considered the availability of other COVID-19 vaccines which provide protection from COVID-19 and have not been shown to present a risk for TTS. However, when other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate for an individual or if that individual chooses to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine, the FDA has determined that the benefits of the vaccine for the prevention of COVID-19 outweigh the risks.
J&J- Fact Sheet for Recipients and Caregivers
---------------------------------------------------------------------------------------------------------------------------------
The Food and Drug Administration (FDA) authorized a second booster dose of either the Pfizer or the Moderna COVID-19 vaccines for individuals 50 years and older and certain immunocompromised individuals. Following this, the Centers for Disease Control and Prevention (CDC) has updated its clinical recommendations to include the following:
Immunocompromised individuals include people with a range of conditions. A full list of conditions can be found on CDC’s website: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html.
Individuals who are immunocompromised or 50 years of age and older may discuss with their health care provider whether getting a second booster dose is appropriate for them. If their health care provider is not at a site administering vaccines, these individuals can self-attest and receive the second booster dose wherever vaccines are offered.
---------------------------------------------------------------------------------------------------------------------------------
For all CDC COVID-19 vaccine interim clinical considerations updates, please visit CDC Interim COVID-19 Vaccine Clinical Recommendations.
----------------------------------------------------------------------------------------------------------------------------------------------
Today, the Food and Drug Administration and the Centers for Disease Control and Prevention shortened the Moderna booster dose interval time to 5 months. Individuals who received the Moderna COVID-19 vaccine as their primary series can now receive a single booster dose 5 months after completing the primary series.
Current Vaccine Fact Sheets:
Pfizer COVID-19 vaccine 5-11 years of age EUA Fact Sheet for Recipients and Caregivers
Pfizer COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
J&J/Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
----------------------------------------------------------------------------------------------------------------------------------------------
CDC has authorized:
----------------------------------------------------------------------------------------------------------------------------------------------
CDC panel endorses Pfizer and BioNTech’s Covid booster shots for 12- to 15-year-olds
The CDC’s vaccine advisory panel on Wednesday endorsed 13-1 third shots of Pfizer and BioNTech’s Covid for adolescents ages 12 to 15 at least five months from their second shot as omicron cases surged across the U.S.
----------------------------------------------------------------------------------------------------------------------------------------------
The CDC updated their vaccination recommendations to include a single booster dose for 16-year and 17-year-olds at least 6 months after completing their primary Pfizer COVID-19 vaccination series.
Important to note, at this time only the Pfizer COVID-19 vaccine is authorized and recommended for adolescents 16-17 years old.
----------------------------------------------------------------------------------------------------------------------------------------------
CDC Recommends Pfizer COVID-19 Vaccine for Ages 5-11
On October 19th, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to allow for the use of the Pfizer COVID-19 vaccine in individuals 5 to 11 years of age.
On November 2nd, Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices unanimously recommended that children in that age range be vaccinated against COVID-19 with the Pfizer vaccine. CDC Director, Dr. Rochelle Walensky, has endorsed that recommendation.
For additional information:
https://www.dshs.texas.gov/coronavirus/immunize/vaccine-faqs.aspx#children
----------------------------------------------------------------------------------------------------------------------------------------------
No problem! You can still get the vaccine for free. When you arrive for your appointment, you'll simply check the "uninsured" section on our form when you're completing your paperwork.
Yes. We'd be happy to provide your second dose, as long as it's the same brand of vaccine as your first dose!
PeopleFirst Pharmacy
2501 E Hebron Pkwy
Carrollton, TX 75010
Make sure you've created your appointment above and received confirmation of your appointment.
Email us at covid19@trinityapothecary.com
Copyright © 2021 Trinity Apothecary - All Rights Reserved.